Adding Imfinzi to FLOT Regimen Improves Cancer-Free Survival in Patients with Gastroesophageal Cancer
Gastric and gastroesophageal junction (GEJ) cancer are among the top five leading causes of cancer mortality globally. In 2025 alone, 1.2 million deaths related to these diseases are expected worldwide. In addition, gastric and esophageal cancers have been …